Schedule 13D ownership disclosure

Timber Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 887080109

Event date: 2021-05-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-079577
Form type
SC 13D/A
Filer
TardiMed Sciences LLC
CIK
CIK 1800690
Filed
Jun 11, 2021
Reporting period
May 28, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub